U.S. Oil and Gas Stock News

NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

Does DXPE’s Mixed Q1 2026 Earnings Hint At A Shift In Its Resilience Story?

DXP Enterprises reported past first-quarter 2026 results showing sales of US$521.66 million versus US$476.57 million a year earlier, while net income eased slightly to US$19.98 million from US$20.59 million. Management highlighted an unexpectedly weak January followed by improving trends through March, raising questions about how temporary this softness might be. Against this backdrop of early-quarter weakness and later recovery, we'll assess how the latest earnings update affects DXP...
NYSE:BEN
NYSE:BENCapital Markets

Will Franklin Resources' Tokenization and Private Markets Partnerships Redefine BEN’s Core Investment Narrative?

In May 2026, Payward, Ritholtz Wealth Management, and Franklin Templeton each announced new collaborations with Franklin Resources, ranging from onchain tokenized products and a momentum-driven equity SMA to blockchain-enabled Private Markets Model Portfolios for advisors. Together, these moves highlight Franklin Resources’ push to blend private markets, quantitative active management, and tokenization to expand how investors access and administer diversified portfolios. We’ll now examine...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

A Look At WD 40 (WDFC) Valuation After Earnings Beat Guidance Raise And Dividend Declaration

Event driven move in WD-40 stock WD-40 (WDFC) is back in focus after Q2 2025 results, where sales growth of 5% missed forecasts, but earnings per share beat expectations, full year profit guidance was raised, and a dividend was declared. See our latest analysis for WD-40. At a share price of US$201.37, WD-40 has given investors a modest 2.34% year to date share price return, while the 1 year total shareholder return has declined 16.76%. This suggests recent momentum has faded despite longer...
NYSE:NHI
NYSE:NHIHealth Care REITs

The Bull Case For National Health Investors (NHI) Could Change Following Q1 2026 Beat And New Guidance

National Health Investors, Inc. reported past first-quarter 2026 results with sales of US$73.15 million, total revenue of US$115.13 million, and net income of US$40.10 million, while also declaring a second-quarter dividend of US$0.92 per common share payable on August 7, 2026. Importantly, management also issued full-year 2026 net income guidance of about US$703.00 million to US$705.20 million, giving investors a clearer view of expected profitability. Next, we’ll examine how this higher...
NYSE:DKL
NYSE:DKLOil and Gas

How Delek Logistics Partners’ (DKL) 2034 Notes and Covenant Shift Has Changed Its Investment Story

Delek Logistics Partners, LP and Delek Logistics Finance Corp. recently issued US$800 million of 6.875% senior notes due 2034 and used part of the proceeds to repurchase approximately US$270.7 million of their 7.125% senior notes due 2028 via a cash tender offer, extending their debt maturity profile and adjusting interest obligations. Beyond the simple refinancing, these moves introduce new covenants that reshape Delek Logistics Partners’ financial flexibility and could influence how it...
NYSE:CCI
NYSE:CCISpecialized REITs

A Look At Crown Castle’s Valuation As Investors Reassess Its Tower Focused Reset

Why Crown Castle is Back on Investors’ Radar Crown Castle (CCI) has drawn renewed attention as investors weigh its current US$86.66 share price against its recent performance, including returns that are down over the past month and the past 3 months. See our latest analysis for Crown Castle. The recent pullback, including a 1-day share price return of 0.74% and a 7-day share price return of 4.42% lower, sits within a weaker picture. The 1-year total shareholder return is down 11.88% and the...
NasdaqGS:EBC
NasdaqGS:EBCBanks

How D.A. Davidson’s First-Time Buy Rating Will Impact Eastern Bankshares (EBC) Investors

D.A. Davidson recently initiated coverage on Eastern Bankshares with a buy rating, marking new analyst attention on the regional bank’s prospects. While the recommendation signals fresh confidence, the analyst’s reported 0.0% one-year success rate adds an unusual context for investors assessing this new view. We’ll now examine how D.A. Davidson’s first-time buy rating might influence Eastern Bankshares’ investment narrative around its regional banking growth. Rare earth metals are the new...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

If AI Small Caps Are Next Then These Three Stocks Matter

Global markets are wrestling with stubborn inflation, higher bond yields and rising energy costs, which puts pressure on traditional playbooks and leaves many investors looking for the next engine of growth. One area drawing attention is smaller companies building real-world AI tools for machine learning, automation and data intelligence. These stocks sit away from the headlines around the mega caps and can sometimes be earlier in their growth journey, which is exactly what the AI Small Caps...
NasdaqGM:EMAT
NasdaqGM:EMATMetals and Mining

Assessing Evolution Metals & Technologies (EMAT) Valuation After Recent Trading Weakness

Evolution Metals & Technologies Stock Moves After Recent Trading Weakness Evolution Metals & Technologies (EMAT) has come onto investors’ radar after a recent stretch of softer trading, with the stock down 11% over the past day and 17% over the past week. See our latest analysis for Evolution Metals & Technologies. The recent drop fits into a wider pattern, with the share price return down over the past quarter and year to date, and the 1 year total shareholder return also in decline. This...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Will Narrowing Losses And Per Share Improvement Reframe Rapport Therapeutics' (RAPP) Investment Narrative?

Rapport Therapeutics, Inc. reported first-quarter 2026 results, posting a net loss of US$19.86 million versus US$24.06 million a year earlier, with basic loss per share from continuing operations improving to US$0.42 from US$0.68. This narrowing loss suggests the company is tightening its cost base or managing its development spending more efficiently, which can reshape how investors assess its progress. We’ll now examine how this narrower quarterly loss and improving per-share results could...
NYSE:UHS
NYSE:UHSHealthcare

A Look At Universal Health Services (UHS) Valuation As Shares Weaken Despite Revenue Growth

Universal Health Services (UHS) has drawn investor attention after its share price closed at US$168.64. The stock has declined over the past month and past 3 months despite recent growth in revenue. See our latest analysis for Universal Health Services. Recent moves show momentum has softened, with the share price down 7.55% over the past 30 days and 28.27% over 90 days, while the 3 year total shareholder return of 26.42% still reflects a much stronger longer term outcome. If this healthcare...
NYSE:BOOT
NYSE:BOOTSpecialty Retail

Assessing Boot Barn (BOOT) Valuation After Record Fiscal 2026 Results And Upbeat 2027 Guidance

Boot Barn Holdings (BOOT) is back in focus after reporting record fiscal 2026 sales of US$2.25b and net income of US$225.9m, along with new guidance indicating further growth and store expansion in fiscal 2027. See our latest analysis for Boot Barn Holdings. Despite the upbeat fiscal 2026 results and fiscal 2027 guidance, the stock has pulled back, with the share price down 11.8% over the past 30 days and 22.9% year to date, while the 3 year total shareholder return of 117.9% still points to...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

A Look At Natera (NTRA) Valuation After Recent Share Price Weakness

Stock performance snapshot and recent context Natera (NTRA) has drawn fresh investor attention after its share price closed at US$186.36, with the stock down 5.4% over the past day and 10.6% over the past month. Over the past 3 months, Natera has fallen 11.8%, while the year-to-date performance shows a decline of 18.6%. Even so, its 1-year total return stands at 21.6%, and the 3-year total return is about 2.5x. See our latest analysis for Natera. Natera’s recent share price weakness,...
NYSE:JXN
NYSE:JXNDiversified Financial

How Investors May Respond To Jackson Financial (JXN) Q1 Losses Paired With Aggressive Capital Returns

In May 2026, Jackson Financial Inc. reported first-quarter 2026 results showing revenue of US$2,902 million versus US$3,750 million a year earlier, alongside a net loss of US$424 million and higher per-share losses from continuing operations. On the same day, the company confirmed ongoing capital returns through a US$0.90 quarterly common dividend, a US$0.50 preferred dividend, and completion of a very large share repurchase program that has retired over two-fifths of its stock since 2021...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Is Radware’s Q1 Beat And Taiwan DDoS Alliance Altering The Investment Case For Radware (RDWR)?

Radware recently reported its first-quarter 2026 results, with sales rising to US$79.81 million while net income and earnings per share eased compared with a year earlier, and it issued revenue guidance of US$81 million to US$82 million for the second quarter. In parallel, Chief Telecom announced a partnership with Radware to launch Godshield Pro, an AI-driven, in-network DDoS protection service for enterprises in Taiwan that aims to combine low latency with access to Radware’s global...
NYSE:PBH
NYSE:PBHPharmaceuticals

Prestige Consumer Healthcare (PBH) Valuation After Missed Q4 Targets And Delayed LaCorium Deal Disclosure

Prestige Consumer Healthcare (PBH) has come under pressure after missing key Q4 FY2026 financial targets and not promptly disclosing its planned US$150 million acquisition of Australian skin care company LaCorium, which has prompted a shareholder investigation. See our latest analysis for Prestige Consumer Healthcare. The share price reaction has been severe, with a 30 day share price return of down 19.6% and a 90 day share price return of down 29.5%. The 1 year total shareholder return is...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

How Investors Are Reacting To Tradeweb Markets (TW) Surging April Volumes Amid Higher Treasury Yields

In early May 2026, Tradeweb Markets Inc. reported April 2026 total trading volume of $62.2 trillion, with average daily volume rising 7.7% year over year to $2.9 trillion, while its platform also captured multi-month highs in key U.S. Treasury yields amid elevated oil prices and inflation concerns. This combination of very large trading volumes and heightened Treasury yield volatility underscores Tradeweb’s central role in fixed income markets during stressed macro conditions. We’ll now...